BioStock Investor Pitch: Neola Medical

Lund-based medical technology company Neola Medical wants to improve the care of premature babies. Therefore, it has developed the Neola system that enables continuous monitoring of the children's lungs, which gives caregivers the opportunity to initiate the right care at the right time and thus give the child the best possible start in life. The company is currently involved in a rights issue of a total of SEK 55 million to prepare the system for launch on the American market. CEO Hanna Sjöström will tell you more about Neola Medical's operations in today's BioStock Investor Pitch at 10:00.